Cover Image
市場調查報告書

全球感染疾病診斷檢驗市場

The World Market for Infectious Disease Diagnostic Tests

出版商 Kalorama Information 商品編碼 96362
出版日期 內容資訊 英文 300 Pages
訂單完成後即時交付
價格
Back to Top
全球感染疾病診斷檢驗市場 The World Market for Infectious Disease Diagnostic Tests
出版日期: 2015年11月01日 內容資訊: 英文 300 Pages
簡介

感染疾病,是現在全球醫療服務遞送系統面臨的最困難的問題。WHO(世界衛生組織),每年估計有1700萬人以上感染疾病死亡,很多是由於院內感染。

本報告提供全球感染疾病診斷檢驗市場相關調查、今後5年的傳染病檢查的趨勢及技術進步的檢討、各實驗類型的市場規模與銷售額預測、主要企業簡介等彙整結果,為您概述為以下內容。

第1章 摘要整理

第2章 簡介

  • 發展的全球傳染病檢查:簡介
    • 公共衛生的反應
    • 資金來源
  • 主要的疾病威脅
  • 主要的傳染病檢查技術
  • 見解

第3章 傳染病檢查趨勢

  • 背景
  • 新的感染疾病的全球化
    • 貿易和旅遊造成的全球化
    • 第三世界的疾病負擔
  • 疫苗
  • 對微生物的抗生素抗性的威脅增加
  • POC檢驗
  • 傳染病檢查的新技術平台
    • 即時PCR
    • 替代核酸擴增法
    • LAMP法
    • NEAR
    • SDA
    • HDA
    • NASBA
    • TMA
    • 定序
    • 質譜分析法
    • 流式細胞技術
  • 彙整

第4章 市場分析概要

  • 背景
    • 傳染病檢查的全球市場
    • 傳染病檢查市場;ID/AST、免疫檢測、分子檢測
    • 全球市場的主要企業
    • 市場上主流的感染疾病

第5章 微生物ID/AST檢驗

  • 背景
  • ID及抗生素敏銳度實驗(AST)
  • 市場分析
  • 各地區明細
  • 市場佔有率
    • 簡易檢驗
    • 微生物鑑定/抗菌藥敏銳度系統
    • 顯象媒體
    • 血液培養
    • 血液培養ID檢驗的供應商的發展
  • ID/AST檢驗的市場展望

第6章 免疫檢測市場

  • 背景
  • 敗血症血清學
  • 肝炎
  • HIV
  • 菌類學
  • 寄生蟲學
  • 呼吸系統
  • ToRCH症候群
  • 性感染疾病(STD)
  • 地區的明細
  • 免疫檢測法傳染病檢查市場展望

第7章 分子檢測市場

  • 背景
  • 市場分析
    • 院內感染(HAI)市場
    • HIV市場
    • 肝炎市場
    • 披衣菌感染/淋病(CT/NG)
    • HPV(人類乳突瘤病毒)
    • 呼吸系統
    • 結核/TB
    • 其他
  • 披衣菌感染/淋病(CT/NG) 、HPV(人類乳突瘤病毒)及性感染疾病(STD);女性的健康
  • 院內感染(HAI)/抗生素抗藥性(AMR)
  • HIV
  • 呼吸系統
  • 分子傳染病檢查市場展望

第8章 感染疾病取向血液篩檢市場

  • 用血液篩檢一般檢查的病原體
  • 市場分析(各類型)
  • 免疫檢測法
  • 核酸檢驗(NAT)
  • 核酸檢驗(NAT)的引進與創新

第9章 企業簡介

  • Abbott Diagnostics
  • Alere
  • Becton, Dickinson and Company (BD)
  • bioMerieux Inc.
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Copan Diagnostics
  • DiaSorin
    • 分子檢測
    • 血液銀行
  • Grifols
  • Blood Screening (Molecular PROCLEIX Tests)
  • Hologic
  • Molecular Cytology / Histology (HPV)
    • 其他分子檢測 (STIs, HIV, HCV, TB, 呼吸系統)
    • 微生物學 (AccuProbe Molecular Culture ID Tests)
    • 血液篩檢 (Molecular PROCLEIX Tests)
  • Meridian Bioscience
  • OraSure Technologies
  • Ortho-Clinical Diagnostics
  • QIAGEN
    • 分子檢測法
    • 免疫檢測
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech
  • Bio-Rad Laboratories Inc.
  • Gen-Probe Inc.
  • Hologic, Inc.
  • QIAGEN N.V.
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific Inc.

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: KLI5721838

Infectious disease tests are one of the most dynamic spaces in the in vitro diagnostics (IVD) industry. Companies in the market need to stay aware of competitive trends and medical trends as occasional explosive market growth in the infectious disease test market can occur with the emergence of new disease threats or acceptance of new routine screening procedures.

This Kalorama Information report, The World Market for Infectious Disease Tests, contains detailed market estimates and forecasts for four major areas of infectious disease testing, including identification and antibiotic susceptibility testing, immunoassays, molecular testing and blood screening. POC and home testing markets for infectious disease are also provided. Specific market details provided include:

  • ID/AST Test Market by Type (Auto ID/AST Systems, Manual ID/AST Systems, Blood Culture, Chromogenic Media, Rapid Micro)
  • Infectious Disease ID/AST Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • ID/AST Leader Market Shares
  • Infectious Disease Immunoassays by Type (Lab-Based, POC, Home Testing)
  • Laboratory Infectious Disease Immunoassays Sales by Disease (Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases, ToRCH, Others)
  • Infectious Disease Immunoassay Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • Infectious Disease Immunoassays Market Share
  • Infectious Disease Molecular Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • Infectious Disease Blood Screening Sales by Type- Immunoassays/NAT
  • Infectious Disease Blood Screening Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020)
  • Infectious Disease Blood Screening Test Market Shares

Infectious diseases are also the frequent target of novel technology applications including PCR-alternative molecular amplification methods, next-generation sequencing (NGS), microarrays, and mass spectrometry. Advancements in instrument automated analysis and microfluidics have allowed for the proliferation of infectious disease testing across settings and institutions - from traditional sites such as reference labs through physician office laboratories (POLs) and mobile clinics in the developing world.

Sales and forecasts of infectious disease reagents are made through to 2020. Emerging products and markets are described; key players and strategies discussed and competitive trends are analyzed.

In addition to providing useful market data for business planning efforts, the report covers important trends in the industry:

Globalization: The process of globalization is relevant to infectious disease through its erosion of spatial and temporal barriers to disease spread and the appropriately globalized response of governments and industry to infectious disease threats and burdens. The new global paradigm for infectious diseases has been demonstrated by several quickly mounting international disease outbreaks in this century - direct products of increased mobility and international trade - and increased engagement of developing world disease burdens by the global in vitro diagnostics (IVD) industry and international organizations. Globalization is also evident through the challenges posed by climate change to disease control and epidemiology.

Antibiotic Resistance: The development of modern healthcare systems across the world and the greater availability and over-prescription of antibiotics worldwide have aided the rise of antibiotic-resistant pathogens, particularly infectious bacteria and fungi in healthcare settings. The development of antimicrobial resistance (AMR) is one of the leading healthcare challenges worldwide, if not the leading existential threat to several healthcare practices. Resistant microbes are most often found in healthcare settings among inpatients left vulnerable to infection due to compromised immune systems, weakened health, or exposure through procedures and devices. The resistance is a product of the microbes' routine exposure to antibiotics or antimicrobials. The dearth of new antibiotic discovery has escalated the threat beyond individual patient outcomes to the underpinnings of modern therapies for infectious disease. According to market player Abbott Diagnostics, effective rapid testing and the earlier detection and identification of AMR and healthcare-acquired infections (HAIs) has the potential to reduce healthcare costs in sepsis and HAI cases by 30%.

Near-Patient For over the past decade, healthcare reform and technological improvements to analyzer and assay technologies have conspired to diversify and intensify point-of-care (POC) and near-patient testing. Near-patient testing includes tests performed in a physician office (either in exam room or dedicated space within office), any form of outpatient clinic (public health, rural, specialty, urgent care, retail), pharmacy, dialysis center, home, workplace, disaster response facility, nursing or long-term care facility, or outside of a centralized lab in a setting that significantly reduces time to results. Testing closer to a patient provides more timely diagnostic information for therapy, and potentially opens new possibilities in diagnosis and treatment in low-resource areas such as in the developing world and rural communities. The expansion of near-patient testing is impeded at times by its disadvantages compared to centralized laboratory testing that may include lower accuracy, precision, and higher test costs.

Major Companies, Profiled and Assessed

  • Alere
  • Beckman Coulter
  • Becton, Dickinson & Co. (BD)
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostics Systems
  • DiaSorin
  • Grifols
  • Hologic
  • Meridian Bioscience
  • OraSure Technologies
  • Ortho-Clinical Diagnostics
  • Qiagen
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech

The information contained in this report has been assembled from primary and secondary data. Secondary data was collected from peer review journals and industry generated press releases. Primary research was conducted via telephone conversation with selected diagnostic marketers of in vitro diagnostics to assess the current market and trends in laboratory medicine.

Table of Contents

ONE: EXECUTIVE SUMMARY

  • Introduction
  • The Globalization of Infectious Diseases
  • Mounting Threat of Microbial Antibiotic Resistance
  • Near-Patient Testing
  • The Global Market for Infectious Disease Tests
    • ID/AST Market
    • Infectious Disease Immunoassay Market
    • Blood Screening Assay Market
  • Major Conclusions

TWO: INTRODUCTION TO INFECTIOUS DISEASES IN HEALTHCARE

  • Introduction to the Evolving World of Infectious Disease Testing
    • Public Health Response
    • Funding Sources
  • Leading Disease Threats
  • Leading Infetious Disease Testing Technologies
  • Point of View

THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES

  • Background
  • The Globalization of Infectious Diseases
    • Globalization Through Trade and Travel
    • Disease Burdens in Developing World
  • Vaccines
  • Mounting Threat of Microbial Antibiotic Resistance
  • Near-Patient Testing
  • New Technology Platforms in Infectious Disease Testing
    • Real-Time PCR
    • Alternative Nucleic Acid Amplification Methods
    • Loop-mediated isothermal amplification (LAMP)
    • Nicking Enzyme Amplification Reaction (NEAR)
    • Strand Displacement Amplification (SDA)
    • Helicase Dependent Amplification (HDA)
    • Nucleic Acid Sequence-Based Amplification (NASBA
    • Transcription-mediated amplification (TMA)
    • Sequencing
    • Mass Spectrometry
    • Flow Cytometry
  • Conclusions

FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET

  • Background
    • The World Market for Infectious disease Tests
    • Infectious Disease Test Markets - ID/AST, Immunoassays, Molecular Assays
    • Major Competitors in the Global Infectious Disease Test Market
    • Market-Leading Infectious Diseases

FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING

  • Background
  • Liquid Microbiology and ID/AST Automation
  • Market Analysis
  • Regional Breakout
  • Market Share
    • Rapid Tests
    • Microbial Identification and Antimicrobial Susceptibility Systems
    • Chromogenic Media
    • Blood Culture
    • Vendor Developments in Blood Culture ID Testing
  • Market Outlook for ID/AST Testing

SIX: THE MARKET FOR IMMUNOASSAYS

  • Background
  • Sepsis Serology
  • Hepatitis
  • HIV
  • Mycology
  • Parasitology
  • Respiratory
  • ToRCH
  • Sexually Transmitted Diseases (STDs)
  • Regional Breakout
  • Market Outlook for Immunoassay Infectious Disease Testing

SEVEN: THE MARKET FOR MOLECULAR ASSAYS

  • Background
  • Market Analysis
    • HAI Market
    • HIV Market
    • Hepatitis Market
    • Chlamydia/Gonorrhea (CT/NG)
    • HPV
    • Respiratory
    • Mycobacteria/TB
    • Other
  • CT/NG, HPV and Sexual Health / Women's Health
  • Healthcare-Acquired Infections (HAIs) / Antimicrobial Resistance (AMR)
  • HIV
  • Respiratory
  • Market Outlook for Molecular Infectious Disease Testing

EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET

  • Commonly Tested Pathogens in Blood Screening
  • Market Analysis by Type
  • Vendor Market Share
  • Immunoassays
  • Nucleic Acid Tests (NATs)
  • Nucleic Acid Test Introductions and Innovations

NINE: COMPANY PROFILES

  • Abbott Diagnostics
  • Alere
  • Beckman Coulter (Danaher)
  • Becton, Dickinson & Co. (BD)
  • bioMérieux
  • Bio-Rad Laboratories
  • Cepheid
  • Chembio Diagnostic Systems
  • Copan Diagnostics
  • DiaSorin
    • Molecular
    • Blood Banking
  • Grifols
  • Blood Screening (Molecular PROCLEIX Tests)
  • Hologic
  • Molecular Cytology / Histology (HPV)
    • Other Molecular (STIs, HIV, HCV, TB, Respiratory)
    • Microbiology (AccuProbe Molecular Culture ID Tests)
    • Blood Screening (Molecular PROCLEIX Tests)
  • Meridian Bioscience
  • OraSure Technologies
  • Ortho-Clinical Diagnostics
  • QIAGEN
    • Molecular Diagnostics
    • Immunoassays
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthcare Diagnostics
  • Thermo Fisher Scientific
  • Trinity Biotech

LIST OF EXHIBITS

  • ONE: EXECUTIVE SUMMARY
  • Figure 1-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year(30 EEA Member Countries/2004-2013) - Methicillin Resistant S. aureus (MRSA)
  • Figure 1-2: Worldwide Infectious Disease Test Market by Region
  • Table 1-2: Worldwide Infectious Disease Test Market by Region/Country North America, Western Europe (EU), Japan, China, India, Latin America,Rest of the World (ROW) (2015-2020)
  • Table 1-3: Worldwide Infectious Disease Test Market by Test Segment - LaboratoryImmunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020)
  • THREE: TRENDS IN CLINICAL INFECTIOUS DISEASES
  • Table 3-1: Infectious Diseases of Globalization and Their Drivers
  • Table 3-2: Disease Preventable Vaccines in 2015
  • Table 3-3: Preventive Vaccines in Development for Infectious Diseases (2015)
  • Figure 3-1: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) - E. coli Resistance to Third-Generation Cephalosporins
  • Figure 3-2: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) - K. pneumoniae Multidrug Resistance to Third-Generation Cephalosporins, Fluoroquinolones and Aminoglycosides
  • Figure 3-3: European Antimicrobial Resistance (AMR) Heat Map By Country/Year (30 EEA Member Countries/2004-2013) - Methicillin Resistant S. aureus (MRSA)
  • Table 3-4: Selected Advanced Antibiotic Resistance Tests
  • Table 3-5: Selected Antibiotic Resistance Facts (CDC)
  • Table 3-6: Selected Advanced Near-Patient Infectious Disease Testing Platforms
  • Table 3-7: Selected Microorganisms and Their Associated Diseases
  • Table 3-8: Selected Isothermal Amplification Methods and Platform Examples
  • Table 3-9: Selected Next Generation Sequencers for Infectious Disease Applications
  • Table 3-10: Selected Infectious Disease Sequencing Innovations
  • Table 3-11: Selected Mass Spectrometry Microbiology Platforms
  • Table 3-12: Selected Flow Cytometry Infectious Disease Applications
  • FOUR: OVERVIEW OF THE INFECTIOUS DISEASE TEST MARKET
  • Table 4-1: Worldwide Infectious Disease Test Market by Region/Country - North America, Western Europe (EU), Japan, China, India, Latin America, Rest of the World (ROW) (2015-2020)
  • Table 4-2: Worldwide Infectious Disease Test Market by Test Segment - Laboratory Immunoassays, Rapid Professional POC Immunoassays, Rapid Home / OTC Immunoassays, ID/AST, Infectious Disease Molecular Assays, Blood Screening Immunoassays, Blood Screening Nucleic Acid Tests (2015-2020) ($ millions)
  • Table 4-3: Global Infectious Disease Test Market Shares - Abbott Diagnostics, Alere, Beckman Coulter, BD, bioMérieux, Bio-Rad Labs, Cepheid, DiaSorin, Grifols, Hologic, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Thermo Fisher Scientific, Others (%)
  • Table 4-4: Worldwide Infectious Disease Test Market by Major Diseases - HAI / AMR, Hepatitis, HIV, Respiratory, STDs / Women's Health, Other Infectious Diseases (2015) ($ millions)
  • FIVE: THE MARKET FOR MICROBIOLOGY ID/AST TESTING
  • Table 5-1: Microbiology Sample/Specimen Types Ranked by Average Volume
  • Table 5-2: Worldwide ID/AST Sales by Segment - Panels and Reagents, Blood Culture, Chromogenic Media, Rapid Micro (2015-2020) ($ millions)
  • Table 5-3: Worldwide ID/AST Sales by Region - North America, Western Europe, Japan, China, India, Latin America, ROW (2015-2020) ($ millions)
  • Table 5-4: ID/AST Leader Market Shares - BD, Beckman Coulter, bioMérieux, Thermo Fisher Scientific, Others
  • Table 5-5: Selected ID/AST System Innovations
  • Table 5-6: Selected Chromogenic Media Innovations and Launches
  • Table 5-7: Selected Blood Culture Innovations and Launches
  • SIX: THE MARKET FOR IMMUNOASSAYS
  • Table 6-1: Selected Sepsis Serology Innovations
  • Table 6-2: Worldwide Infectious Disease Immunoassay Sales by Segment - Lab-Based, Rapid / POC (2015-2020) ($ millions)
  • Table 6-3: Worldwide Infectious Disease Immunoassay Sales by Region - North America, Western Europe, Japan, China, India, Latin America,
  • ROW (2015-2020) ($ millions)
  • Table 6-4 Alere, Beckman Coulter, bioMérieux, Bio-Rad Laboratories, DiaSorin, Meridian Bioscience, Ortho-Clinical Diagnostics, Quidel, Roche Diagnostics, Siemens Healthcare Diagnostics, Trinity Biotech, Others
  • Table 6-5: Laboratory Infectious Disease Immunoassays Sales by Disease or Pathogen - Hepatitis, HIV, Mycology, Parasitology, Respiratory, Sepsis, Sexually Transmitted Diseases (STDs), ToRCH, Others (2015)
  • Table 6-6: Selected Laboratory Infectious Disease Immunoassay Innovations
  • Table 6-7: CLIA-Waived Infectious Disease Tests and Analytes
  • Table 6-8: Rapid Infectious Disease Immunoassays Sales by Disease or Pathogen - C. difficile, E. coli, H. pylori, Hepatitis, HIV, Influenza, Malaria, Strep A, STDs, Others (2015)
  • Table 6-9: Selected Rapid Infectious Disease Immunoassay Innovations
  • SEVEN: THE MARKET FOR MOLECULAR ASSAYS
  • Table 7-1: Selected Moderate and Waived Complexity Molecular Infectious Disease Testing Platforms
  • Table 7-2: Worldwide Molecular Infectious Disease Assay Sales by Disease Area - CT/NG, HAIs, Hepatitis, HIV, HPV, Mycobacteria/TB,
  • Respiratory, Others (2015-2020)
  • Table 7-3 bioMérieux, Cepheid, Hologic, QIAGEN, Roche Diagnostics, Siemens Healthcare Diagnostics, Others
  • Table 7-4: Selected Molecular Sexual Health and Women's Health Test Introductions and Innovations
  • Table 7-5: Selected Molecular Healthcare-Acquired Infection (HAI) / Antimicrobial Resistance (AMR) Test Introductions and Innovations
  • Table 7-6: Selected Molecular Hepatitis Test Introduction and Innovations
  • Table 7-7: Selected Molecular HIV Test Introduction and Innovations
  • Table 7-8: Selected Molecular Respiratory Infection Test Introduction and Innovations 178
  • EIGHT: THE INFECTIOUS DISEASE BLOOD SCREENING MARKET
  • Table 8-1: Commonly Tested Pathogens in Blood Screening
  • Table 8-2: Worldwide Infectious Disease Blood Screening Test Sales - Immunoassays and Nucleic Acid Tests (NATs) (2015-2020) ($ millions)
  • Table 8-3: Infectious Disease Blood Screening Test Market Shares - Abbott Diagnostics, DiaSorin, Grifols, Hologic, Ortho-Clinical Diagnostics, Roche Diagnostics, Others
  • Table 8-4: Selected Blood Screening Immunoassay Introductions and Innovations Nucleic Acid Tests (NATs)
  • Table 8-5: Selected Blood Screening Nucleic Acid Test Introductions and Innovations.. 195
  • NINE: COMPANY PROFILES
  • Table 9-2: Alere Revenue (2011-2014)
  • Table 9-3: Beckman Coulter Revenue (2011-2014)
  • Table 9-4: Becton, Dickinson & Co. (BD) Revenue (FY 2011-2014)
  • Table 9-5: bioMérieux Revenue (2011-2014)
  • Table 9-6: Bio-Rad Laboratories Revenue (2011-2014)
  • Table 9-7: Cepheid Revenue (2011-2014)
  • Table 9-8: Chembio Diagnostics Systems Revenue (2011-2014)
  • Table 9-9: DiaSorin Revenue (2011-2014)
  • Table 9-10: Grifols Revenue (2011-2014)
  • Table 9-11: Hologic Revenue (FY 2011-2014)
  • Table 9-12: Meridian Bioscience Revenue (2011-2014)
  • Table 9-13: OraSure Technologies Revenue (2011-2014)
  • Table 9-14: Ortho-Clinical Diagnostics Revenue (2011-2014)
  • Table 9-15: QIAGEN Revenue (2011-2014)
  • Table 9-16: Quidel Corporation Revenue (2011-2014)
  • Table 9-17: Roche Diagnostics Revenue (2011-2014)
  • Table 9-18: Siemens Healthcare Diagnostics Revenue (FY 2011-2014)
  • Table 9-19: Thermo Fisher Scientific Revenue (2011-2014)
  • Table 9-20: Trinity Biotech Revenue (2011-2014)
Back to Top